Evidence map›Paper›PMID 39152124›Full record

ArticleScientific reports2024

Experimentally altering microRNA levels in embryos alters adult phenotypes.

Zeynep Yilmaz Sukranli, Keziban Korkmaz Bayram, Serpil Taheri, Francois Cuzin, Yusuf Ozkul, Minoo Rassoulzadegan

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zeynep Yilmaz Sukranli *Betul-Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.
Keziban Korkmaz Bayram *Betul-Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.
Serpil TaheriBetul-Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.
Francois CuzinINSERM-CNRS, Université de Nice, Nice, France.
Yusuf OzkulBetul-Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.
Minoo RassoulzadeganBetul-Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey. minooh@wanadoo.fr.

Funding

La Fondation Nestlé France 2019-2020 -RASSOULZADEGANTübitak, 1010 EVRENA project ID 112S570 a grant to Y. Ozkul.
6 · The paper itself

Abstract

We previously identified a unique genetic feature of Autism Spectrum Disorder (ASD) in human patients and established mouse models, a low to very low level of six microRNAs, miR-19a-3p, miR-361-5p, miR-3613-3p, miR-150-5p, miR-126-3p and miR-499a-5p. We attempted to interfere experimentally in mice with two of them, miR19a-3p and miR499a-5p by microinjecting into zygote pronuclei either the complementary sequence or an excess of the microRNA. Both resulted in low levels in the tissues and sperm of the targeted microRNAs and their pri and pre precursors. This method stably modify predetermined levels of miRNAs and identify miRNA alterations that cause changes in autistic behavior and predispose the individual to an inherited disease. Excess miRNA results in single-stranded miRNA variations in both free and DNA-bound RNA (R-loop) fractions in mouse models thus appearing to affect their own transcription. Analysis of miRNAs fractions in human patients blood samples confirm low level of six microRNAs also in R-loop fractions.

Indexed as

MicroRNAsPhenotypeAdultAnimalsAutism Spectrum DisorderDisease Models, AnimalEmbryo, MammalianFemaleHumansMaleMiceMicroRNAsAutismBehaviorBloodHereditymiRNANon-MendelianOocyteR-loopVariations

Identifiers

PMID39152124
PMCPMC11329699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.